We previously demonstrated that deregulated expression, activity and phosphorylation of GSK3β are distinct features of gastrointestinal cancers and glioblastoma and that GSK3β sustains the survival and proliferation of these tumor cells. This evidence concerns the gene GSK3B and glioblastoma.